• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Ashleigh Furlong

Stay informed with Ashleigh Furlong’s coverage and analysis.

Bill Gates
Health
Gates Foundation partners with Indian drugmakers to speed rollout of $40 HIV shot
By Janice Kew, Ashleigh Furlong and BloombergSeptember 24, 2025
AstraZeneca to buy cell therapy biotech for up to $1 billion
Tech
AstraZeneca to buy cell therapy biotech for up to $1 billion
By Ashleigh Furlong and BloombergMarch 17, 2025
WHO offers early retirement to cut costs ahead of U.S. exit
Health
WHO offers early retirement to cut costs ahead of U.S. exit
By Bloomberg, Ashleigh Furlong and Naomi KresgeMarch 7, 2025
Sanofi profit lifted by early vaccine sales, dupixent growth
Finance
Sanofi profit lifted by early vaccine sales, dupixent growth
By Ashleigh Furlong, Tim Loh and BloombergOctober 25, 2024
balding head
Health
Hair loss drug probed in Europe over link to suicidal thoughts
By Ashleigh Furlong and BloombergOctober 4, 2024
Zantac heartburn medicine are seen at a store in Mountain View, California
Retail
Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit, but thousands still to come
By Jef Feeley, Ashleigh Furlong and BloombergMay 24, 2024
Emma Walmsley attends the 10th Annual Breakthrough Prize Awards and Ceremony at the Academy Museum of Motion Pictures in Los Angeles, California, United States
Health
How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
By Ashleigh Furlong, Sabah Meddings and BloombergMay 21, 2024
Pascal Soriot, chief executive officer of AstraZeneca Plc.
Retail
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By Ashleigh Furlong and BloombergMay 21, 2024
woman measures her waist
Health
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By Ashleigh Furlong and BloombergMay 11, 2024
Pascal Soriot, CEO of AstraZeneca. Under Soriot, Astra has invested heavily in cancer drugs.
Retail
AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs
By Ashleigh Furlong and BloombergApril 25, 2024
A person using Ozempic
Retail
Wegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations
By Ashleigh Furlong and BloombergMarch 13, 2024
1
  • 1
1
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.